Sir, We thank Kö ser et al.
1 for their valuable comments on our paper 2 and note with interest the association of specific single nucleotide polymorphisms (SNPs) with Mycobacterium tuberculosis strain lineages; the mutation at position -46 in the oxyR -ahpC intergenic region with the Central Asian (CAS) lineage and the C to T mutation in oxyR with East African -Indian (EAI) lineage strains. This corroborates some of our own recent observations 3 in a study conducted in a country that neighbours Myanmar (India), where we showed by SNP analysis of the pncA gene (conferring resistance to pyrazinamide) a CAS lineage-specific silent mutation, S65S, which is observed for the majority of CAS lineage isolates. There seems to be a somewhat mixed view with regard to the role of the frequent mutation in the oxyR-ahpC intergenic region at position -46. In a study by Baker et al.,
4 among 378 strains, the oxyR-ahpC mutation was present in 23.7% of isoniazid-resistant isolates and 7.5% of susceptible isolates. Although a phylogenetic marker for a subgroup of M. tuberculosis strains originating on the Indian subcontinent (CAS), this marker is strongly associated with isoniazid resistance and the katG 315Thr mutation.
